Abstract
Get full access to this article
View all access options for this article.
References
1.
Rogiers
A
,
Wolter
P
,
Op de Beeck
K
,
Thijs
M
,
Decallone
B
,
Schöffski
P
. 2010 . Shrinkage of thyroid volume in sunitinib treated patients with renal cell carcinoma—a potential marker of irreversible thyroid dysfunction? Thyroid , 20 :317 –322 .
2.
Makita
N
,
Miyakawa
M
,
Fujita
T
,
Iiri
T
. 2010 . Sunitinib induces hypothyroidism with a markedly reduced vascularity . Thyroid , 20 :323 –326 .
3.
Wong
E
,
Rosen
LS
,
Mulay
M
,
Vanvugt
A
,
Dinolfo
M
,
Tomoda
C
,
Sugawara
M
,
Hershman
JM
. 2007 . Sunitinib induces hypothyroidism in advanced cancer patients and may inhibit thyroid peroxidase activity . Thyroid , 17 :351 –355 .
4.
Rini
BI
,
Tamaskar
I
,
Shaheen
P
,
Salas
R
,
Garcia
J
,
Wood
L
,
Reddy
S
,
Dreicer
R
,
Bukowski
RM
. 2007 . Hypothyroidism in patients with metastatic renal cell carcinoma treated with sunitinib . J Natl Cancer Inst , 99 :81 –83 .
5.
Feldman
DR
,
Martorella
AJ
,
Robbins
RJ
,
Motzer
RJ
. 2007 . Re: Hypothyroidism in patients with metastatic renal cell carcinoma treated with sunitinib . J Natl Cancer Inst , 99 :974 –975 author reply 976–977.
6.
Desai
J
,
Yassa
L
,
Marqusee
E
,
George
S
,
Frates
MC
,
Chen
MH
,
Morgan
JA
,
Dychter
SS
,
Larsen
PR
,
Demetri
GD
,
Alexander
EK
. 2006 . Hypothyroidism after sunitinib treatment for patients with gastrointestinal stromal tumors . Ann Intern Med , 145 :660 –664 .
7.
Mannavola
D
,
Coco
P
,
Vannucchi
G
,
Bertuelli
R
,
Carletto
M
,
Casali
PG
,
Beck-Peccoz
P
,
Fugazzola
L
. 2007 . A novel tyrosine-kinase selective inhibitor, sunitinib, induces transient hypothyroidism by blocking iodine uptake . J Clin Endocrinol Metab , 92 :3531 –3534 .
8.
Wolter
P
,
Stefan
C
,
Decallonne
B
,
Dumez
H
,
Bex
M
,
Carmeliet
P
,
Schoffski
P
. 2008 . The clinical implications of sunitinib-induced hypothyroidism: a prospective evaluation . Br J Cancer , 99 :448 –454 .
9.
Faris
JE
,
Moore
AF
,
Daniels
GH
. 2007 . Sunitinib (sutent)-induced thyrotoxicosis due to destructive thyroiditis: a case report . Thyroid , 17 :1147 –1149 .
10.
Alexandrescu
DT
,
Popoveniuc
G
,
Farzanmehr
H
,
Dasanu
CA
,
Dawson
N
,
Wartofsky
L
. 2008 . Sunitinib-associated lymphocytic thyroiditis without circulating antithyroid antibodies . Thyroid , 18 :809 –812 .
11.
Grossmann
M
,
Premaratne
E
,
Desai
J
,
Davis
ID
. 2008 . Thyrotoxicosis during sunitinib treatment for renal cell carcinoma . Clin Endocrinol (Oxf ) , 69 :669 –672 .
12.
de Groot
JW
,
Zonnenberg
BA
,
Plukker
JT
,
van Der Graaf
WT
,
Links
TP
. 2005 . Imatinib induces hypothyroidism in patients receiving levothyroxine . Clin Pharmacol Ther , 78 :433 –438 .
13.
Sherman
SI
,
Wirth
LJ
,
Droz
JP
,
Hofmann
M
,
Bastholt
L
,
Martins
RG
,
Licitra
L
,
Eschenberg
MJ
,
Sun
YN
,
Juan
T
,
Stepan
DE
,
Schlumberger
MJ
. 2008 . Motesanib diphosphate in progressive differentiated thyroid cancer . N Engl J Med , 359 :31 –42 .
14.
Salem
AK
,
Fenton
MS
,
Marion
KM
,
Hershman
JM
. 2008 . Effect of sunitinib on growth and function of FRTL-5 thyroid cells . Thyroid , 18 :631 –635 .
15.
Kamba
T
,
Tam
BY
,
Hashizume
H
,
Haskell
A
,
Sennino
B
,
Mancuso
MR
,
Norberg
SM
,
O'Brien
SM
,
Davis
RB
,
Gowen
LC
,
Anderson
KD
,
Thurston
G
,
Joho
S
,
Springer
ML
,
Kuo
CJ
,
McDonald
DM
. 2006 . VEGF-dependent plasticity of fenestrated capillaries in the normal adult microvasculature . Am J Physiol Heart Circ Physiol , 290 :H560 –576 .